Grant Sanders - Instadose Pharma Founder Officer
| INSD Stock | USD 0 0.00 0.00% |
Insider
Grant Sanders is Founder Officer of Instadose Pharma Corp
| Address | 5500 North Service Road, Burlington, ON, Canada, L7L 6W6 |
| Phone | 905 218 3593 |
| Web | https://www.instadosepharma.com |
Instadose Pharma Management Efficiency
The company has return on total asset (ROA) of (694.0616) % which means that it has lost $694.0616 on every $100 spent on assets. This is way below average. Instadose Pharma's management efficiency ratios could be used to measure how well Instadose Pharma manages its routine affairs as well as how well it operates its assets and liabilities. At present, Instadose Pharma's Return On Equity is projected to increase slightly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 623.27, whereas Net Tangible Assets are projected to grow to (138.8 K).Similar Executives
| Showing other executives | INSIDER Age | ||
| Karen Smith | Emergent Biosolutions | 52 | |
| Lynn Kieffer | Emergent Biosolutions | N/A | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| Keith Katkin | Emergent Biosolutions | 48 | |
| CPA CPA | Intracellular Th | 68 | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| Robert Sr | Emergent Biosolutions | 67 | |
| Norman MD | Durect | 72 | |
| Andrew Miksztal | Durect | N/A | |
| Steve JD | Durect | N/A | |
| Marvin White | Emergent Biosolutions | 58 | |
| Jennifer Fox | Emergent Biosolutions | 51 | |
| James DVM | Durect | 68 | |
Management Performance
| Return On Asset | -694.06 |
Instadose Pharma Corp Leadership Team
Elected by the shareholders, the Instadose Pharma's board of directors comprises two types of representatives: Instadose Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Instadose. The board's role is to monitor Instadose Pharma's management team and ensure that shareholders' interests are well served. Instadose Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Instadose Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Antonio Franchino, CEO Chairman | ||
| LLB JD, Chief Officer | ||
| Grant Sanders, Founder Officer | ||
| Lawrence Acton, Chief Officer |
Instadose Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Instadose Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -694.06 | ||||
| Current Valuation | 757.11 K | ||||
| Shares Outstanding | 531.93 M | ||||
| Shares Owned By Insiders | 34.03 % | ||||
| Price To Book | 0.02 X | ||||
| EBITDA | (462.02 K) | ||||
| Net Income | 462.02 K | ||||
| Cash And Equivalents | 5.33 K | ||||
| Total Debt | 162.3 K | ||||
| Debt To Equity | 0.01 % |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Instadose Pharma Corp is a strong investment it is important to analyze Instadose Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instadose Pharma's future performance. For an informed investment choice regarding Instadose Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Instadose Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instadose Pharma. If investors know Instadose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instadose Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Instadose Pharma Corp is measured differently than its book value, which is the value of Instadose that is recorded on the company's balance sheet. Investors also form their own opinion of Instadose Pharma's value that differs from its market value or its book value, called intrinsic value, which is Instadose Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instadose Pharma's market value can be influenced by many factors that don't directly affect Instadose Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instadose Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.